The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 3540 -3547
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803588

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Pottier, L.
Right arrow Articles by Pers, J.-O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Pottier, L.
Right arrow Articles by Pers, J.-O.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Joint Disorders
*Salivary Gland Disorders
*Sjogren's Syndrome

Ectopic Germinal Centers Are Rare in Sjögren’s Syndrome Salivary Glands and Do Not Exclude Autoreactive B Cells1

Laëtitia Le Pottier*, Valérie Devauchelle*,{dagger}, Alain Fautrel{ddagger}, Capucine Daridon*, Alain Saraux*,{dagger}, Pierre Youinou2,*,{dagger} and Jacques-Olivier Pers*,{dagger}

* Equipe d'Accueil 2216 and Institut Fédératif de Recherche 418, Science et Ingénierie en Biologie-Santé, Université de Brest, Brest, and Université Européenne de Bretagne, Brest, France; {dagger} Centre Hospitalier Universitaire de Brest, Brest, France; {ddagger} Institut National de la Santé et de la Recherche Médicale Unité 620, and Institut Fédératif de Recherche 140 Core Histopathology Platform, Université de Rennes I, and Université Européenne de Bretagne, Rennes, France

This study reports on the characterization of B cells of germinal center (GC)-like structures infiltrating the salivary glands (SGs) of patients with Sjögren’s syndrome. Eight two-color combinations were devised to characterize the phenotype of these B cells in 11 SG specimens selected from biopsies obtained from 40 Sjögren’s syndrome patients and three normal tonsils. The 9G4 mAb, which recognizes V4.34-encoded autoAbs, enabled us to identify autoreactive B cells. Quantitative RT-PCR was used to determine the level of mRNAs for activation-induced cytidine deaminase (AICDA), repressors and transcription factors. CD20+IgDCD38+CD21+CD24 B cells, similar to those identified in tonsil GCs, were seen in the SGs of four patients and, and since they expressed AICDA, they were termed "real GCs". CD20+IgD+CD38CD21+CD24+ B cells, seen in aggregates from the remaining seven samples, were characteristically type 2 transitional B cells and marginal zone-type B cells. They lacked AICDA mRNAs and were termed "aggregates". Real GCs from SGs contained mRNAs for Pax-5 and Bcl-6, like tonsil GC cells, whereas aggregates contained mRNAs for Notch-2, Blimp-1, IRF-4, and BR3, similar to marginal zone B cells. Further experimental data in support of this dichotomy included the restriction of CXCR5 expression to real GC cells, while sphingosine 1-phosphate receptor 1 was expressed only in aggregates. In contrast, both types of B cell clusters expressed the idiotype recognized by the 9G4 mAb. Our data indicate that, in SGs, a minority of B cell clusters represent genuine GC cells, while the majority manifest features of being type 2 transitional B cells and marginal zone cells. Interestingly, both types of B cell aggregates include autoreactive B cells.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the French Ministry for Education and Research.

2 Address correspondence and reprint requests to Dr. Pierre Youinou, Laboratory of Immunology, Brest University Medical School Hospital, BP 824, F29609 Brest, France. E-mail address: youinou{at}univ-brest.fr

3 Abbreviations used in this paper: SS, Sjögren’s syndrome; BT1 and BT2, type 1 and type 2 transitional B cells; BR3, BAFF receptor 3; BAFF, B cell-activating factor of the TNF family; FO, follicle/follicular; FDC, follicular dendritic cell; GC, germinal center; TF, transcription factor; MZ, marginal zone; S1P1, sphingosine 1-phosphate receptor 1; AID, activation-induced cytidine deaminase; PC, plasma cell; SLE, systemic lupus erythematosus; SG, salivary gland; FM, follicular mantle; TRITC, tetramethylrhodamine isothiocyanate; LT, lymphotoxin; AICDA, activation-induced cytidine deaminase.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
T. R. Reksten, M. V. Jonsson, E. A. Szyszko, J. G. Brun, R. Jonsson, and K. A. Brokstad
Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome
Rheumatology, September 1, 2009; 48(9): 1102 - 1106.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.